Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that utilizes best-in-class, proprietary genome editing technologies to develop targeted, life-saving therapeutics in areas of high unmet medical need. We have demonstrated proof-of-principle that validates the potential of our differentiated genome engineering technologies and their therapeutic applications.